We’re improving our website: We’re making improvements to the look and navigation of our website to make it easier to find the information you need. You may notice some pages looking a little different while these updates are being made.
Tofacitinib for treating juvenile idiopathic arthritis in people from 2 years old up to their 16th birthday, Policy Position Statement (PP229), May 2022.pdf (PDF, 311Kb)